NCT06389292 2025-11-25A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid LeukemiaAscentage Pharma Group Inc.Phase 3 Recruiting486 enrolled
NCT04501120 2025-09-26Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AMLAscentage Pharma Group Inc.Phase 1/2 Recruiting458 enrolled